Waystar Holding

WAY · NYSE · Healthcare · United States

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$791.0M$791.0M$943.5M$943.5M$1.1B$1.1B10.2% margin10.2% marginRevenueNet margin

Quarterly · last 8

Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26$224.8M$224.8M$234.5M$234.5M$240.1M$240.1M$256.4M$256.4M$270.7M$270.7M$268.7M$268.7M$313.9M$313.9M$319.7M$319.7M12.8% margin12.8% marginRevenueNet margin

Revenue (FY2025)

$1.1B

Net margin

10.2%

ROE

2.9%

Revenue CAGR (2y)

+17.9%

EPS (FY2025)

0.61

Net profit (FY2025)

$112.1M

Ask MarketChacha about WAY

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

  • Aug 25, 2026

    Waystar Holding shares fell with no identifiable company-specific catalyst in filings or today's coverage; the decline likely reflected broader market or sector movement.

    · confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$1.1B$112.1M0.6110.2%2.9%
FY2024$943.5M$-19.1M-0.13-2.0%-0.6%
FY2023$791.0M$-51.3M-0.42-6.5%-2.5%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q2$319.7M$40.9M0.2112.8%
2026Q1$313.9M$43.3M0.2213.8%
2025Q3$268.7M$30.6M0.1711.4%
2025Q2$270.7M$32.2M0.1811.9%
2025Q1$256.4M$29.3M0.1611.4%
2024Q3$240.1M$5.4M0.032.3%
2024Q2$234.5M$-27.7M-0.21-11.8%
2024Q1$224.8M$-15.9M-0.13-7.1%
2023Q3$197.3M$-15.5M-0.13-7.9%
2023Q2$196.0M$-10.8M-0.09-5.5%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.